All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| HTGM / HTG Molecular Diagnostics Inc
|
|
|
|
|
|
|
|
| BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
| US0909311062 / BioSpecifics Technologies Corp.
|
|
|
|
|
|
|
|
| CEMI / Chembio Diagnostics Inc.
|
|
|
|
|
|
|
|
| MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| / Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
| US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
|
|
|
|
|
|
|
|
| CORV / Correvio Pharma Corp. (Canada)
|
|
|
|
|
|
|
|
| DMAC / DiaMedica Therapeutics Inc.
|
|
|
|
|
|
|
|
| US16706W1027 / Chiasma Inc
|
|
|
|
|
|
|
|
| ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| MTNB / Matinas BioPharma Holdings, Inc.
|
|
|
|
|
|
|
|
| US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| VIVE / Viveve Medical, Inc.
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| APVO / Aptevo Therapeutics Inc.
|
|
|
|
|
|
|
|
| CPIX / Cumberland Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| IDXG / Interpace Biosciences, Inc.
|
|
|
|
|
|
|
|
| OPNT / Opiant Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| EBS / Emergent BioSolutions Inc.
|
|
|
|
|
|
|
|
| ALIM / Alimera Sciences, Inc.
|
|
|
|
|
|
|
|
| XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
